Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies

Previous reports have shown that some tyrosine kinase inhibitors (TKIs) could inhibit the ATP-binding cassette (ABC) transporters involved in multidrug resistance (MDR). Quizartinib (AC220), a potent class III receptor tyrosine kinase inhibitor (TKI), was synthesized to selectively inhibit FMS-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Kumar, Priyank, Anreddy, Nagaraju, Zhang, Yun-Kai, Wang, Yi-Jun, Chen, Yanglu, Talele, Tanaji T., Gupta, Kanav, Trombetta, Louis D., Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706835/
https://www.ncbi.nlm.nih.gov/pubmed/29212189
http://dx.doi.org/10.18632/oncotarget.21078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706835/
https://www.ncbi.nlm.nih.gov/pubmed/29212189
http://dx.doi.org/10.18632/oncotarget.21078

Ejemplares similares